Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2

Pierre Colas, Barak Cohen, Timm Jessen, Irina Grishina, John McCoy, Roger Brent

Research output: Contribution to journalArticlepeer-review

393 Scopus citations


A network of interacting proteins controls the activity of cyclin dependent kinase 2 (Cdk2) and governs the entry of higher eukaryotic cells into S phase. Analysis of this and other genetic regulatory networks would be facilitated by intracellular reagents that recognize specific targets and inhibit specific network connections. We report here the expression of a combinatorial library of constrained 20-residue peptides displayed by the active-site loop of Escherichia coli thioredoxin, and the use of a two-hybrid system to select those that bind human Cdk2. These peptide aptamers were designed to mimic the recognition function of the complementarity-determining regions of immunoglobulins. The aptamers recognized different epitopes on the Cdk2 surface with equilibrium dissociation constant in the nanomolar range; those tested inhibited Cdk2 activity. Our results show that peptide aptamers bear some analogies with monoclonal antibodies, with the advantages that they are isolated together with their coding genes, that their small size should allow their structures to be solved, and that they are designated to function inside cells.

Original languageEnglish
Pages (from-to)548-550
Number of pages3
Issue number6574
StatePublished - Apr 11 1996


Dive into the research topics of 'Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2'. Together they form a unique fingerprint.

Cite this